Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$547.06
+0.2%
$567.63
$512.12
$623.61
$8.00B0.54105,026 shs245,728 shs
CorVel Corp. stock logo
CRVL
CorVel
$102.11
-0.4%
$110.65
$81.46
$128.61
$5.24B1.02119,739 shs180,794 shs
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$179.31
-0.3%
$174.45
$135.47
$182.38
$20.02B0.49991,721 shs1.02 million shs
DaVita Inc. stock logo
DVA
DaVita
$136.66
+0.6%
$139.84
$131.76
$179.60
$10.32B1.11804,663 shs1.71 million shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
0.00%-0.59%-3.85%-9.86%+0.85%
CorVel Corp. stock logo
CRVL
CorVel
0.00%-2.82%-7.48%-7.98%+25.21%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.00%-0.40%+4.65%+7.15%+29.04%
DaVita Inc. stock logo
DVA
DaVita
0.00%+0.54%-1.19%-9.23%-3.34%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Chemed Corporation stock logo
CHE
Chemed
4.6829 of 5 stars
2.53.03.34.93.52.51.3
CorVel Corp. stock logo
CRVL
CorVel
0.9815 of 5 stars
0.02.00.00.03.23.30.0
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4.8757 of 5 stars
2.34.04.24.72.52.52.5
DaVita Inc. stock logo
DVA
DaVita
4.3683 of 5 stars
2.01.00.04.52.51.74.4
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chemed Corporation stock logo
CHE
Chemed
3.00
Buy$674.0023.20% Upside
CorVel Corp. stock logo
CRVL
CorVel
0.00
N/AN/AN/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.69
Moderate Buy$185.733.58% Upside
DaVita Inc. stock logo
DVA
DaVita
2.00
Hold$164.5020.37% Upside

Current Analyst Ratings Breakdown

Latest CRVL, DGX, DVA, and CHE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
DaVita Inc. stock logo
DVA
DaVita
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$170.00 ➝ $164.00
5/6/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$180.00 ➝ $190.00
4/28/2025
Chemed Corporation stock logo
CHE
Chemed
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.00
4/28/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.00
4/23/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$182.00 ➝ $190.00
4/23/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$175.00 ➝ $180.00
4/23/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$175.00 ➝ $185.00
4/23/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$191.00 ➝ $194.00
4/9/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$178.00 ➝ $189.00
4/2/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$195.00
4/2/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$195.00
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chemed Corporation stock logo
CHE
Chemed
$2.43B3.29$25.64 per share21.34$74.35 per share7.36
CorVel Corp. stock logo
CRVL
CorVel
$895.59M5.85$2.43 per share42.06$6.27 per share16.29
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$9.87B2.03$13.49 per share13.29$61.38 per share2.92
DaVita Inc. stock logo
DVA
DaVita
$12.82B0.81$19.09 per share7.16$4.83 per share28.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chemed Corporation stock logo
CHE
Chemed
$302M$20.5326.6523.482.2812.40%27.58%18.96%7/23/2025 (Estimated)
CorVel Corp. stock logo
CRVL
CorVel
$95.17M$1.8455.60N/A10.63%32.55%18.22%7/29/2025 (Estimated)
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$871M$7.9122.6717.092.508.81%15.11%6.65%7/22/2025 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$936.34M$10.0913.5410.750.946.63%176.11%4.66%8/5/2025 (Estimated)

Latest CRVL, DGX, DVA, and CHE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/22/2025Q4 2025
CorVel Corp. stock logo
CRVL
CorVel
N/A$0.51N/A$0.51N/A$231.51 million
5/12/2025Q1 2025
DaVita Inc. stock logo
DVA
DaVita
$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion
4/23/2025Q1 2025
Chemed Corporation stock logo
CHE
Chemed
$5.59$5.63+$0.04$4.86$641.78 million$646.94 million
4/22/2025Q1 2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Chemed Corporation stock logo
CHE
Chemed
$2.000.37%N/A9.74%16 Years
CorVel Corp. stock logo
CRVL
CorVel
N/AN/AN/AN/AN/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.201.78%N/A40.46%14 Years
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A

Latest CRVL, DGX, DVA, and CHE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/14/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.801.86%7/7/20257/7/20257/21/2025
5/20/2025
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.500.3%5/29/20255/29/20256/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chemed Corporation stock logo
CHE
Chemed
N/A
1.73
1.70
CorVel Corp. stock logo
CRVL
CorVel
N/A
1.90
1.90
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.84
1.44
1.31
DaVita Inc. stock logo
DVA
DaVita
23.18
1.25
1.20

Institutional Ownership

CompanyInstitutional Ownership
Chemed Corporation stock logo
CHE
Chemed
95.85%
CorVel Corp. stock logo
CRVL
CorVel
51.36%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
DaVita Inc. stock logo
DVA
DaVita
90.12%

Insider Ownership

CompanyInsider Ownership
Chemed Corporation stock logo
CHE
Chemed
3.29%
CorVel Corp. stock logo
CRVL
CorVel
47.57%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
8.16%
DaVita Inc. stock logo
DVA
DaVita
2.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chemed Corporation stock logo
CHE
Chemed
15,69514.63 million14.15 millionOptionable
CorVel Corp. stock logo
CRVL
CorVel
5,07551.35 million26.92 millionOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
56,000111.64 million102.53 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
76,00075.50 million73.99 millionOptionable

Recent News About These Companies

Buffett Stock Portfolio: Top 10 Stock Picks for 2025
DaVita Inc. stock logo
DaVita Inc. (NYSE:DVA) Shares Sold by Tobam

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Chemed stock logo

Chemed NYSE:CHE

$547.06 +0.98 (+0.18%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$548.06 +1.00 (+0.18%)
As of 06/20/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CorVel stock logo

CorVel NASDAQ:CRVL

$102.11 -0.39 (-0.38%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$102.10 0.00 (0.00%)
As of 06/20/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$179.31 -0.47 (-0.26%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$177.82 -1.49 (-0.83%)
As of 06/20/2025 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

DaVita stock logo

DaVita NYSE:DVA

$136.66 +0.87 (+0.64%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$136.78 +0.12 (+0.09%)
As of 06/20/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.